top of page

Questions & answers on Article 20 non-pharmacovigilance procedures

This guidance document addresses a number of questions which stakeholders, in particular marketing authorisation holders (MAHs), may have on an Article 20 non-pharmacovigilance procedure. It provides an overview of the European Medicine Agency’s (the Agency) practical and operational aspects with regards to the handling of Article 20 non-pharmacovigilance procedures.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page